{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-011241","form_type":"8-K","ticker":"ULBI","cik":"0000875657","company_name":"ULTRALIFE CORP","filed_at":"2023-04-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.515394+00:00","generated_at":"2026-06-16T10:33:43.830566+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ultralife Q1: revenue $31.9M (+5.1%), net loss $0.3M due to ransomware disruption","bullets":["Revenue $31.9M, +5.1% YoY; operating income breakeven vs loss $0.3M last year.","Net loss $0.3M ($0.02/share) vs net loss $0.2M ($0.01/share) in Q1 2022.","Ransomware attack discovered Jan 25, 2023; no ransom paid; $0.1M cyber insurance deductible recorded.","Gov/defense sales +24.7%; Communications Systems sales +181.8% to $3.4M on vehicle-amplifier adaptor order.","Total backlog $108.1M, with $96.1M shippable in 9 months, up 30.2% YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-011241","json":"https://secwatch.observer/filing/0001437749-23-011241.json","markdown":"https://secwatch.observer/filing/0001437749-23-011241.md","text":"https://secwatch.observer/filing/0001437749-23-011241.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875657/000143774923011241/0001437749-23-011241-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875657/000143774923011241/ulbi20230426_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T10:33:43.830566+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5ca0461e8d7418b593fc7cb9ad8dfbc9258fef04","claim":"ULTRALIFE CORP reported first quarter ended March 31, 2023 results: revenue $31.9 million, net income Net loss was $0.3 million or $0.02 per diluted share, EPS $0.02 per diluted share.","evidence_excerpt":"Ultralife Corporation (NASDAQ: ULBI) reported breakeven operating income and adjusted EBITDA of $1.2 million on revenue of $31.9 million for the first quarter ended March 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/875657/000143774923011241/0001437749-23-011241-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$31.9 million"},{"label":"Net income","value":"Net loss was $0.3 million or $0.02 per diluted share"},{"label":"EPS","value":"$0.02 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}